|Ms Lynne Murray BAppSci FAIMS|
Research Manager, ANZIC-RC, and Research Centre Manager, Blood-CRE
Phone: +61 3 9903 0347
Mobile: +61 (0) 419 155 983
Lynne is the ANZIC-RC's Research Manager and the Blood-CRE's Research Centre Manager. She is an Associate Investigator for the POLAR-RCT (Prophylactic hypOthermia trial to Lessen trAumatic bRain injury Randomised Control Trial) Study and the Blood Program. She was the Project Manager for the DECRA (DECompressive CRAniectiomy) Trial. Lynne has extensive research experience in both basic science and clinical research. Her previous roles include the Clinical Research Manager (Intensive Care) at The Alfred Hospital, Lecturer in Biochemistry at Swinburne University of Technology and Research and Development Officer (Haematology/Blood Bank) at The Alfred.
|Ms Amanda Martin BA(Soc) MA(Couns)|
Administration Manager and PA to the Director, ANZIC-RC
Phone: +61 3 9903 0343
Mobile: +61 (0) 421 915 395
Amanda is the ANZIC-RC Administration Manager and PA to the Director, Professor Jamie Cooper. With diverse experience both in Australia and in the USA, Amanda has worked in the private, community, local government, health and education sectors, including roles in administration, counselling and dispute resolution. Her qualifications include a Bachelor's degree in Sociology and a Master's degree in Counselling.
|Professor (DJ) Jamie Cooper AO BMBS MD FRACP FCICM FAHMS|
Professor Cooper is Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC); Director of the NHMRC Centre of Research Excellence for Patient Blood Management in Critical Illness and Trauma (Blood-CRE); Head of the Critical Care Division in the School of Public Health and Preventive Medicine, all at Monash University; and Senior Specialist in Intensive Care, Head of ICU Research and Deputy Director of the Department of Intensive Care at The Alfred Hospital, Melbourne. In 2017, he was awarded an Officer of the Order of Australia (AO) for distinguished service to intensive care medicine in the field of traumatic brain injury as a clinician, and to medical education as an academic, researcher and author. He is a National Health and Medical Research Council (NHMRC) Practitioner Fellow, full Professor of Intensive Care Medicine at Monash University and Hon. Professorial Fellow in the Critical Care and Trauma Division at The George Institute for Global Health, University of Sydney. He has published more than 250 journal papers including 18 in New England Journal of Medicine (NEJM), Lancet, Journal of the American Medical Association (JAMA) and Annals of Internal Medicine. He has been a Principal or Co-investigator on peer reviewed research grants exceeding $55 million including 24 NHMRC grants. Research foci include randomised clinical trials in traumatic brain injury, sepsis, acute lung injury, resuscitation fluids, and blood transfusion.
|Professor Rinaldo Bellomo AO MBBS MD PGDipEcho PhD FRACP FCICM FAHMS|
Rinaldo Bellomo is a Professor of Intensive Care Medicine, University of Melbourne, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of Sydney, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Honorary Fellow, Florey Institute of Physiology, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Nanjing University, Nanjing, China; and Visiting Professor, Università Vita-Salute San Raffaele, Milan, Italy. In 2018, he was awarded an Officer of the Order of Australia for distinguished service to intensive care medicine as a biomedical scientist and researcher, through infrastructure and systems development to manage the critically ill, and as an author.
Professor Bellomo is the Director of Intensive Care Research and Staff Specialist in Intensive Care at Austin Health. He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) – a National Health and Medical Research Council (NHMRC) Enabling Grant-funded methods centre for investigator initiated clinical research that supports >15 staff, >10 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG).
Each year for the past four years (2014-2017), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Thomson Reuters publishes "The world's most influential scientific minds" based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognize as vital to the advancement of their science". He is also the recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award.
In 2015, Professor Bellomo became the first ANZ biomedical researcher to have more than 1,000 papers in Scopus. He has also written more than 152 book chapters and edited 13 books in the field of intensive care medicine. As at May 2018, in Scopus he had >1,200 papers, an h index of 109, and total lifetime citations of >61,000; and a yearly citation rate over the past 5 years of >2,500. He is the Editor-in-Chief of the journal Critical Care and Resuscitation.
Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in The Lancet and the New England Journal of Medicine (NEJM) for >20,000 intensive care unit (ICU) patients randomised.
|Professor Alistair Nichol MBBCh BAO(Hons) BA(Hons) DipMan PhD FCARCSI FJFICMI FCICM|
Co-Deputy Director ANZIC-RC and Professor of Intensive Care Medicine
Alistair is a Professor of Intensive Care Medicine in the School of Public Health and Preventive Medicine, Monash University, and an honorary intensivist in The Alfred Hospital, Melbourne. Following completion of a PhD at University College Dublin, Alistair commenced with the ANZIC-RC in 2007 and has worked on a number of its large multi-centre randomised controlled trials. He is actively involved with the POLAR-RCT (Prophylactic hypOthermia trail to Lessen trAumatic bRain injury Randomised Control Trial) and the PHARLAP studies. He was also a Chief Investigator on the now completed EPO-TBI (Erythropoietin in Traumatic Brain Injury) Study. His areas of interest include traumatic brain injury (TBI), acute respiratory distress syndrome (ARDS) and mechanical ventilation. Alistair has completed over 10 years of training in Anaesthesia, Intensive Care and Pain Medicine. He was awarded the Fellowship of the College of Anaesthetists, Royal College of Surgeons Ireland (FCARCSI) in 2002, and the Fellowship of the College of Intensive Care Medicine Australia and New Zealand (FCICM) in 2010. Alistair was also awarded a Victorian Neurotrauma Initiative (VNI) Early Career Practitioner Fellowship.
|Professor Andrew Udy MB ChB BHB PGCert(AME) PhD FCICM|
Co-Deputy Director ANZIC-RC and Professor of Intensive Care Medicine
Andrew is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, and a full-time intensive care clinician and researcher at The Alfred ICU, Melbourne. He completed his undergraduate medical education at the University of Auckland, followed by ICU training in New Zealand, the United Kingdom and Australia. After award of Fellowship, Andrew worked as a consultant for many years in Queensland, while also completing a PhD in antibiotic pharmacokinetics. His major academic interests include optimised drug prescribing in the critically ill, haemodynamic management in severe sepsis, acute kidney injury and renal replacement therapy, management of subarachnoid haemorrhage, and critical care nutrition. Andrew is involved in critical care research internationally as the Victorian representative on the ANZICS Clinical Trials Group (CTG) Committee. He is also a keen educator, instructing on BASIC, ALS, ECMO and EMST courses, and is Deputy Chair of the Victorian Regional Committee (VRC), College of Intensive Care Medicine.
|Associate Professor Carol Hodgson BAppSci(Physio) PGDip(Cardio) M(Research) PhD FACP|
Co-Deputy Director ANZIC-RC and Associate Professor
Phone: +61 3 9903 0598
Mobile: +61 (0) 448 674 532
Carol is Deputy Director of the Australian and New Zealand Intensive Care Research Centre in the Department of Epidemiology and Preventive Medicine at Monash University. She leads international trials in mechanical ventilation (PHARLAP) and early mobilisation (TEAM) in ICU. She specialises in long term functional outcomes following ICU and organ support, including ECMO. She is a senior physiotherapist in ICU at the Alfred Hospital and is passionate about multidisciplinary research to improve patient recovery.
|Professor Steve Webb MBBS MPH PhD FRACP FCICM FAHMS|
Professor of Critical Care Research
Prof Steve Webb is a Senior Staff Specialist in Intensive Care Medicine at Royal Perth Hospital and a Professor of Critical Care Research in the School of Public Health and Preventive Medicine at Monash University. He also holds adjunct Professorial appointments at the University of Western Australia and The George Institute for Global Health.
Steve is a trialist who designs and conducts clinical trials that provide definitive guidance on optimal management for patients with various forms of critical illness. He is a recipient of more than $80M in research funding and has published more than 140 original journal articles including manuscripts in the NEJM (4), JAMA (1), Lancet (2), and BMJ (1).
He is a past-Chair of the ANZICS Clinical Trials Group. He is the Vice-Chair of the International Forum of Acute Care Trialists, and a member of the Executive of the International Severe Acute Respiratory Illness Consortium. He is a founding Director of the Australian Clinical Trials Alliance, a foundation Fellow and a member of Council of the Australian Academy of Health and Medical Sciences, and a member of the NHMRC Health Translation Advisory Committee.
His clinical research interests include pandemic preparedness, pneumonia, the long-term consequences of and recovery after critical illness, resuscitation and treatment of patients with septic shock, management of traumatic brain injury, pathogenesis of septic shock, antimicrobial therapy, acute kidney injury, sedation and prevention of delirium, and choice of intravenous fluids in critically ill patients. He is a lead investigator of SPRINT-SARI (Short Period Incidence Study of Severe Acute Respiratory Infection) and REMAP-CAP (Randomised, Embedded, Multifactorial, Adaptive, Platform Trial of Community Acquired Pneumonia). He has particular interest in novel and more efficient trial methods including Platform Trials using Bayesian statistical methods and cluster-crossover trials, as well as the interface between clinical trials and healthcare policy.
|Professor Michael Bailey BSc(Hons) MSc PhD|
Mobile: +61 (0) 417 391 513
Michael is a researcher specialising in Intensive Care. He has completed a Master's degree in statistics and a PhD in mathematical modelling. Michael has been employed as a biostatistician with Monash University for more than 20 years. His background in medical research prior to Intensive Care was founded on a decade as the principal statistical consultant for one of the largest tertiary and research hospitals in Australia, providing him with a diverse and thorough understanding of medical statistics. In 2007 he was appointed as the biostatistician for the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), and in 2016 promotion to Professor. Since commencing with the ANZIC-RC, Michael has become the most heavily published intensive care statistician in the world, and amongst the top 10 most published Intensive Care authors in the world. His reputation has been built on rigorous analyses resulting in robust findings that are heavily cited by his peers (>20,000 citations). His research output is prolific, having authored >450 peer reviewed publications with >60 as lead or senior author. These manuscripts are consistently published in the highest impact journals (15 publications in the New England Journal of Medicine, The Lancet and JAMA). His h-index is 70 and his i10-index is 270. He has been the principal statistician for >50 successfully funded NHMRC studies worth >$70 million. Michael has provided statistical direction and guidance to >130 PhD students. Michael is on the editorial board of 2 international journals, is a reviewer for a further 15 journals, and has provided statistical review for >300 publications.
|Associate Professor Daryl Jones MBBS BSc(Hons) MD PhD FRACP FCICM|
Daryl is an Associate Professor of Intensive Care Medicine in the School of Public Health and Preventive Medicine at Monash University. In 2015, he completed his PhD thesis entitled "The Rapid Response Team: Patient characteristics and resource implications" under the supervision of Professors Rinaldo Bellomo and Graeme Hart. The first area of investigation involved assessment of the uptake of MET services in intensive care unit (ICU) equipped hospitals in Australia and New Zealand, particularly in relation to published literature supporting their effectiveness. In conjunction with the Australian Commission for Quality and Safety in Health Care (ACQSHC) and Australian and New Zealand Intensive Care Society Centre for Outcomes and Resources Evaluation (ANZICS-CORE), a 40 hospital study was conducted to assess: 1) the changes in MET call rates with time, and 2) the in-hospital mortality of MET patients in comparison to hospitalized patients. The second major area of the PhD involved assessment of the epidemiology of the MET patient. A seven hospital study was completed to perform a detailed analysis of the role of METs in end-of-life care planning in hospitalized patients. It also assessed the circadian activation of MET calls to confirm or refute the findings seen at the Austin Hospital. Finally, the thesis included several reviews related to MET systems and the broader concept of deteriorating patients. This thesis has provided new insights into the causes and outcomes of deterioration in hospitalized Australian patients, and will lead to strategies to improve the outcomes and safety of hospital admissions.
|Dr Zoe McQuilten PhD FRACP FRCPA|
Senior Research Fellow, ANZIC-RC
Phone: +61 3 9903 0379
Mobile: +61 (0) 425 207 735
Dr Zoe McQuilten is a consultant haematologist and an ANZIC-RC Senior Research Fellow (SRF) working with the Blood CRE. Zoe is an investigator on the TRANSFUSE RCT, an Associate Investigator on the Blood-CRE and is also an investigator on the Massive Transfusion Registry. Zoe completed her PhD in 2015 in the area of transfusion medicine, and has previously been a Clinical Research Fellow with the Australian Red Cross Blood Service. Zoe was awarded Fellowships of the Royal Australasian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA) in 2010 and has current appointments at St Vincent's Hospital Melbourne and Monash Health.
|Dr Emma Ridley BNutDietet MPH PhD APD|
Senior Research Fellow and Nutrition Program Manager
Phone: +61 3 9903 0350
Mobile: +61 (0) 430 200 804
Emma leads the ICU Nutrition Research Program at the Australian and New Zealand Intensive Care Research Centre, Melbourne, Australia and has 13 years of clinical dietetic experience, including as a senior dietitian in the ICU at The Alfred Hospital, Melbourne. Emma’s research interests include the clinical application of indirect calorimetry, as well as the effect of optimal nutrition delivery on short and long-term outcomes in ICU patients. Emma was awarded a prestigious Churchill Fellowship in 2011 to investigate the role of indirect calorimetry internationally. She regularly delivers invited national and international presentations. Emma is on the management committee for the TARGET trial (the largest blinded enteral nutrition trial conducted in critical care) and has been a named investigator on $6.2 million of research funding, including a project based on findings from her PhD of $2.4 million (NCT03292237).
|Dr Glenn Eastwood PhD|
Senior Research Fellow and Chief Investigator TAME Cardiac Arrest
Mobile: +61 (0) 439 354 596
Glenn is a Chief Investigator for the Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest randomised controlled trial (TAME Cardiac Arrest Trial). Dr Eastwood holds a Research Doctorate (PhD) with Deakin University in research dedicated to oxygen therapy for patients at risk of respiratory dysfunction. His research program is focused on the impact and outcome of gas management (oxygen and carbon dioxide) in critically ill patients and he has published widely in this area. Glenn also currently manages the Intensive Care research program at the Austin Hospital and is widely acknowledged as a leading research coordinator within the Australian and New Zealand Intensive Care Society - Clinical Trials Group (ANZICS-CTG). In addition, he is the Vice-Chair of the Australian and New Zealand Intensive Care Research Coordinator Interest Group (IRCIG), an Australian College of Critical Care Nurses (ACCCN) member, and a peer reviewer for Australian Critical Care, Critical Care, Critical Care and Resuscitation and the Journal of Clinical Nursing.
|Ms Lisa Higgins BPhysio(Hons) GDipBiostat MPH|
Research Fellow and PhD Scholar, ANZIC-RC
Mobile: +61 (0) 400 658 694
Lisa has a background in intensive care physiotherapy, and previously worked as an intensive care research coordinator at The Alfred Hospital in Melbourne. More recently she worked at the NHMRC Clinical Trials Centre at the University of Sydney conducting systematic reviews and economic evaluations in addition to teaching epidemiology and biostatistics to Master in Public Health (MPH) students. Lisa has an MPH majoring in epidemiology and biostatistics and a Graduate Diploma in Biostatistics. She recently commenced a PhD in the economic analysis of resuscitation in sepsis.
|Ms Emma Donoghue BAppSci(Hons) MMusThy MPH|
Research Fellow (Currently on maternity leave)
Mobile: +61 (0) 404 334 377
Emma works as a Research Fellow on the CENTER-TBI project, a multinational European project that aims to improve the care of patients with TBI. In this role she provides intensive methods support to novice author teams as they prepare and publish living systematic reviews in various TBI topics. Emma joined ANZIC-RC in April 2016, and has previously had various roles in organisations such as the Cochrane Collaboration, the National Trauma Research Institute, NHMRC, NICE (UK), and the AIHW. Emma has a Masters of Public Health, and Masters of Music Therapy.
|Ms Oana Tatucu-Babet BNut(Hons) |
Phone: +61 3 9905 6643
Oana is a Dietitian working at the ANZIC-RC on a part-time basis, assisting with research projects being completed within the nutrition program. Oana is currently completing her PhD at La Trobe University, with the focus area of her research on the measurement of segmental intestinal permeability in critically ill patients and healthy adults. She has previously been involved in projects exploring energy requirements in patients receiving ExtraCorporeal Membrane Oxygenation, and has an interest in gastrointestinal dysfunction during critical illness, as well as the use of indirect calorimetry in guiding nutrition delivery.
|Ms Kate Lambell BHSc MNutDiet APD |
Mobile: +61 (0) 413 600 871
Kate has over 10 years’ experience working as a clinical dietitian and has a special interest in ICU nutrition, nutrition support and body composition analysis. Kate is a PhD candidate at La Trobe University, with a research focus on the evaluation of bedside methods to assess skeletal muscle mass in critically ill adults. Kate is assisting with research projects within the ANZIC-RC nutrition program in a part-time capacity.
|Ms Lorraine Little BHSC (Nursing) GradCert Intensive Care MBioethics RN|
Senior Project Manager – TARGET Study
Phone: +61 3 9903 0513
Mobile: +61 (0) 437 207 413
Lorraine joined the ANZIC-RC team in February 2009 as the EPO-TBI (Erythropoietin in Traumatic Brain Injury) Study Project Manager, and she is now the Project Manager for the TARGET Study. Lorraine was the Safety Officer for the now completed ARISE Study. Prior to her appointment with the ANZIC-RC, Lorraine worked at The George Institute for International Health as a Clinical Research Associate. Her previous roles include Research and Ethics Manager, Ethics Submission Coordinator for a cancer research group, and Intensive Care Unit (ICU) Research Coordinator at the highly productive Western Health Intensive Care Unit. Lorraine's background is in clinical ICU nursing. She has a strong interest in bioethics and completed a Master in Bioethics degree in 2000.
|Ms Belinda Howe BASc(Nursing) MPH RN CCN |
Senior Project Manager – SPICE-EGDS Study
Phone: +61 3 9903 0340
Mobile: +61 (0) 413 433 414
Belinda joined the ANZIC-RC in 2009 as an ANZIC-RC Research Fellow and Project Manager. The last decade has seen her manage multiple and varied research projects to successful completion with particular expertise in managing large, complex, international RCTs. She is currently the Project Manager for the SPICE-EGDS RCT, which is the largest RCT of sedation practices in the world. She previously managed the SPICE observational study and the SPICE pilot study. She was the Project Manager for the STATINS (STATINS in Sepsis) and the unblinded monitor for the EPO-TBI RCT. She was Project Manager for the INFINITE Registry, a register of Influenza A and pandemic H1N109 cases in intensive care units (ICUs) for Australia and New Zealand. This was the only bi-national whole of population register during the H1N1 pandemic of 2009. The ARISE-RCT (Australasian Resuscitation In Sepsis), the largest study of early goal-directed therapy, was successfully completed under her management and she was also involved in the harmonisation of the international trials of early goal-directed therapy for severe sepsis and septic shock which resulted in the individual patient data meta-analysis (IPDMA) of the EGDT trials.
Belinda has an extensive background in critical care nursing and worked as a research coordinator in ICU for over 10 years. Belinda has a Master's degree in Public Health. In addition, she is a past Chair of the ANZICS Intensive Care Research Coordinator Interest Group (IRCIG), past ANZICS Clinical Trials Group executive committee member, and she implemented the IRCIG mentor program for research coordinators in ANZ and the IRCIG Terms of Reference during her tenure as chair. She is a past member of the Australian College of Critical Care Nurses (ACCCN) research advisory panel. She is currently a peer reviewer for the ANZICS CTG and a member of the Intensive Care Foundation Scientific Review Committee.
|Mr Tony Trapani BEd BEmergHealth(Pmed) CCC(Alfred) RN|
Project Manager – POLAR and OzENTER-TBI Studies
Phone: +61 3 9903 0034
Mobile: +61 (0) 409 798 892
Tony joined the ANZIC-RC team in November 2010 as the POLAR-RCT (Prophylactic hypOthermia trial to Lessen trAumatic bRain injury Randomised Control Trial) Project Manager, and is now also the Project Manager for the OzENTER-TBI Study. He is a qualified Paramedic (Monash) and Critical Care Nurse, and also holds a BEd (Latrobe). Tony has worked in the critical care environment for over 20 years and has spent most of his career as a Clinical Educator in The Alfred Intensive Care Department. He has also held the role of Nurse Unit Manager at Western Health Intensive Care Unit.
|Ms Victoria King BNSc GCert MPH CCRN|
Project Manager – INTENT Study
Phone: +61 3 9903 0280
Mobile: +61 (0) 409 367 132
Victoria joined the ANZIC-RC team in January 2012 as the PHARLAP-RCT Project Manager and is now the Project Manager for the INTENT Study. Prior to her work at the ANZIC-RC, Vic was an Intensive Care Unit Research Coordinator at The Alfred Hospital. She has a clinical background in Critical Care Nursing, and completed her Master's degree in Public Health in 2013.
|Ms Bridget Ady BHIM MClinEpi|
Project Manager – TAME Study
Phone: +61 3 9903 0035
Mobile: +61 (0) 400 504 164
Bridget joined the ANZIC-RC team in February 2012 as the TRANSFUSE-RCT (Standard issue tranfusion versus fresher red blood cell use in intensive care - randomised controlled trial) Project Manager. She is currently the Project Manager for the TAME study. Prior to this, Bridget was employed as a Haemotology Unit Research Coordinator at St Vincent's Hospital. She has a Master's degree in Clinical Research Methods.
|Ms Genevieve O'Neill BNSc MPH RN|
Project Manager – REMAP-CAP
Phone: +61 3 9903 0247
Mobile: +61 438 146 617
Genevieve joined the ANZIC-RC team in August 2014 as the PREPARE Project Manager working on pandemic preparedness. She is currently the Project Manager for REMAP-CAP (Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia). Previously she was the SPRINT-SARI Project Manager. Prior to this appointment, Genevieve was a Program Officer at Inner North West Melbourne Medicare Local, with a clinical background in Critical Care Nursing since 2004. She completed her Master's degree in Public Health, including an internship at the Centre for Health Communication and Participation, at La Trobe University.
|Dr Maya George PhD|
Project Manager – SPRINT-SARI
Phone: +61 3 9903 0217
Maya joined the ANZIC-RC team in May 2016 as the SPRINT-SARI (Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection) Project Manager. Maya previously worked as a Research Fellow at the Cardiovascular Research Institute at the National University Hospital (Singapore), working on a collaborative project along with the Biomedical Research Council, Health Science Authority and the Genomic Institute to develop a real-world, adverse reaction prediction platform using clinical, electronic medical records, genomic and pharmacokinetic data in the Asian population. Maya has a PhD in Pharmacy, and is passionate about roles at the intersection of science and business, with an emphasis on new and innovative strategies that can improve the healthcare system.
|Ms Meredith Young BN GCert(IntCareNurs) MPH RN|
Project Manager – PHARLAP
Phone: +61 3 9903 0280
Meredith joined the ANZIC-RC team in June 2014 as the ICU-Recovery Project Manager. Currently she is the Project Manager for the PHARLAP study. She is also an ICU Research Coordinator at the Alfred Hospital. Meredith completed her Master's degree in Public Health in 2012.
|Dr Veronica Pitt PhD|
Project Manager – PATCH
Phone: +61 3 9903 0391
Veronica is the Project Manager for the PATCH study (Prehospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage). Prior to this role, she has had extensive experience in conducting systematic reviews and supporting evidence-based decision-making in clinical practice and government policy. She has been responsible for training and mentoring clinicians in evidence-based medicine as part of the Neurotrauma Evidence Translation (NET) program at the National Trauma Research Institute (NTRI) and as a trainer for the Australasian Cochrane Centre. Veronica has worked with many health service, university and corporate partners to complete a range of projects and reports commissioned by Government and statutory organisations to inform policy decisions related to the delivery of health care services. Outcomes of these projects have been published in high impact medical journals. She completed her PhD at the Peter MacCallum Cancer Centre in 2004, investigating cellular changes and early development of colon cancer.
|Ms Janani Sivasuthan BBiomedSc (Hons)|
Project Manager – TEAM
Phone: +61 3 9903 0932
Janani joined the ANZIC-RC team in March 2017 as the TEAM (Treatment of invasively ventilated adults with Early Activity and Mobilisation) Project Manager. Prior to this role, she worked as a Clinical Trial Manager at the Peter MacCallum Cancer Centre where she managed a large number of oncology trials over an extensive period of time. Janani has strong experience in data management and project management of clinical trials from both working in the industry and research institutions. She is currently studying a Master of Public Health, specialising in Epidemiology and Biostatistics.
|Ms Vanessa Singh |
Phone: +61 3 9903 0263
Vanessa commenced at the ANZIC-RC in 2014 as an Admin and Research Officer. She has been a Project Manager for both the TRANSFUSE and TAME Trials. Vanessa has experience working in Fiji and New Zealand, largely for academic institutes in the area of distance learning and health research. She has had roles in administration, electronic publishing, real estate advertising and clinical data management. Her data management experience includes working on randomised controlled trials related to heart health, health IT (mobile technologies), nutrition and exercise, addiction and aged care.
|Ms Jane Parker RN |
Phone: +61 3 9903 0937
Mobile: +61 (0) 401 626 628
Jane joins the ANZIC-RC as the Project Officer for the TARGET Randomised Control Trial. Jane is a registered nurse with a keen interest in health outcomes and using data to inform research and policy development. Jane previously worked for the Australian and New Zealand Intensive Care Society (ANZICS) with the Centre for Outcome and Resource Evaluation (CORE) coordinating the ANZICS Critical Care Resources (CCR) Registry. Jane also works as a Registered Nurse at Western Health, and has recently commenced a Master's degree in Public Health at The University of Melbourne.
|Ms Natalie Linke BN GCert(IntCareNurs)|
Project Officer – PREDICT and ICU-ROX Studies
Phone: +61 3 9903 0995
Mobile: +61 (0) 400 145 477
Natalie joined the ANZIC-RC in March 2017 as the Project Officer for the ICU-ROX trial (Intensive Care Unit Randomised Trial Comparing Two Approaches to Oxygen Therapy). Natalie is also the Project Officer for the PREDICT study (a registry in critically ill patients to determine predictors of disability-free survival). She continues to work as a Clinical Nurse Specialist at The Alfred ICU where she is completing her Masters of Nursing in Research. Natalie has experience in industry, having previously worked in the United Kingdom for medical companies Vygon and Smith & Nephew.